Related Experiment Video
Updated: Jan 27, 2026

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
Published on: September 11, 2013
Phyllodes tumor with a benign heterologous osseous component: a diagnostic challenge
Lene Gaarsmand Christensen1, Tina Di Caterino1, Maj-Lis Talman2
1Department of Pathology, Odense University Hospital, Odense, Denmark.
Abstract:
Phyllodes tumors (PTs) are rare fibroepithelial neoplasms of the breast and constitute 0.3-1% of all primary breast tumors. They should be characterized in to a benign, borderline or malignant category based on a combination of histological features. PTs can show heterologous components, typically sarcomatous, including osteosarcomatous and chondrosarcomatous. Benign heterologous components are exceedingly rare with only one prior reported case in the English literature. This case emphasizes how difficult establishing a correct diagnosis in PTs with heterologous components can be, especially when the tumor consists mainly of a benign heterologous component. We report the case of a 65 year old woman with a recurrent breast tumor initially misdiagnosed as benign osseous metaplasia. The tumor re-occurred as a malignant PT dominated by benign osseous and chondroid metaplasia. Multiple metastases consisting of primarily mature bone and cartilage were seen in the lungs. On microscopic revision and considering the clinical course the primary breast tumor was re-classified as a borderline PT.
Related Concept Videos
Components of Stress
Interestingly, the hidden cube faces also experience these stresses, equal and...
Components of Language
Curvilinear Motion: Rectangular Components
As the car advances, its position evolves over time. Quantifying the car's velocity involves computing the...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Vector Algebra: Method of Components
In many applications, the magnitudes and directions of...
Electron Transport Chain Components

